Medical Imaging to Re-evaluate Elacestrant Clinical Usage

Clinical trial NCT07753954 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07753954
Sponsor: Jules Bordet Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ER+ / HER2- Advanced Breast Cancer

Start date: 2026-09-13
Primary completion: 2031-08-19
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.